Suzuken
Suzuken is a Japanese pharmaceutical company founded in 1932 and headquartered in Nagoya. It operates through four main segments: Pharmaceutical Wholesale, which focuses on the sale of pharmaceuticals, diagnostic drugs, and medical equipment; Pharmaceutical Manufacturing, which produces these drugs and diagnostics; Insurance Pharmacy, which dispenses medications based on prescriptions; and Medical-related Services, which includes the sale of medical literature, nursing services, and the production of physiological examination equipment. With a comprehensive approach that spans research, development, and support for pharmaceutical manufacturers, Suzuken has established itself as a unique entity in the medical field.
Top Regions
Top Stages
11 past transactions
Frontier Field
Series C in 2023
Frontier Field is a venture company that brings the medical and healthcare fields together with the power of IT. It also engaged in the planning, development, sales, and maintenance of the nibyo mobile smartphone exclusively for medical institutions.
Oishi Kenko
Series C in 2022
Oishi Kenko Inc. is a Tokyo-based company founded in 2016 that focuses on promoting health through food. The company publishes films centered on cooking, the wisdom of living, and the significance of maintaining a healthy mindset. Additionally, Oishi Kenko offers a recipe search and menu creation service, which is supervised by a registered dietitian. This service aims to assist individuals in preventing and managing diseases while promoting healthy eating habits. Through its multifaceted approach, Oishi Kenko emphasizes the philosophy that delicious food can contribute to overall well-being.
Ubie
Series C in 2022
Ubie, Inc. is a Tokyo-based company founded in 2017 that specializes in developing artificial intelligence-powered healthcare solutions. Its core offering is an AI-driven symptom checker that generates personalized evaluation reports for patients. Through a brief questionnaire that customizes its inquiries based on factors such as biological sex, age, medical history, and lifestyle choices, the tool aims to assist users in understanding potential causes of their symptoms. In addition to providing patients with detailed reports, Ubie also supplies physicians with patient summaries and predictive diagnoses to enhance clinical decision-making.
DOCTORS
Series B in 2021
Doctors offer a healthcare platform that provides digital health services. They offer development support, distribution support, sales support, medical cooperation-type online medical support, digital health services, planning and development, marketing, and environmental support.
Embrace Japan
Acquisition in 2021
Embrace Co., Ltd. is a Tokyo-based company that specializes in the development of a medical caring station platform designed to enhance medical treatment and information sharing among hospitals, clinics, nursing facilities, and drugstores. Founded in 2003, the company aims to facilitate communication within an integrated community care system, allowing medical professionals to exchange real-time information. This capability supports the optimization of medical care, treatment, and prevention activities, ultimately improving patient outcomes. Embrace's approach combines expertise from various fields, including IT and pharmaceuticals, to address significant challenges in the medical care sector.
DOCTORS
Venture Round in 2020
Doctors offer a healthcare platform that provides digital health services. They offer development support, distribution support, sales support, medical cooperation-type online medical support, digital health services, planning and development, marketing, and environmental support.
Stella Pharma
Corporate Round in 2020
Stella Pharma Corporation is a Japan-based company established in 2007 and headquartered in Osaka. It specializes in the research, development, and marketing of boron-based pharmaceuticals, particularly for applications in boron neutron capture therapy (BNCT), a targeted cancer treatment that aims to destroy cancer cells effectively. As a subsidiary of Stella Chemifa Corporation, Stella Pharma is dedicated to advancing medical care through the innovation of prescription drugs, focusing on the therapeutic potential of boron compounds in oncology.
Ubie
Series B in 2020
Ubie, Inc. is a Tokyo-based company founded in 2017 that specializes in developing artificial intelligence-powered healthcare solutions. Its core offering is an AI-driven symptom checker that generates personalized evaluation reports for patients. Through a brief questionnaire that customizes its inquiries based on factors such as biological sex, age, medical history, and lifestyle choices, the tool aims to assist users in understanding potential causes of their symptoms. In addition to providing patients with detailed reports, Ubie also supplies physicians with patient summaries and predictive diagnoses to enhance clinical decision-making.
Susmed
Venture Round in 2020
Susmed develops therapeutic smartphone applications and digital solutions that streamline clinical trials. Its product portfolio includes apps for conditions such as insomnia, breast cancer, and kidney disease. The company also offers the Susumed System, a blockchain‑based platform that enhances the reliability of clinical trial data while reducing personnel and cost requirements. Susmed’s operations are organized into two segments: the DTx Product Business, focused on therapeutic app development, and the DTx Platform Business, which provides a general‑purpose clinical trial platform.
Embrace Japan
Venture Round in 2020
Embrace Co., Ltd. is a Tokyo-based company that specializes in the development of a medical caring station platform designed to enhance medical treatment and information sharing among hospitals, clinics, nursing facilities, and drugstores. Founded in 2003, the company aims to facilitate communication within an integrated community care system, allowing medical professionals to exchange real-time information. This capability supports the optimization of medical care, treatment, and prevention activities, ultimately improving patient outcomes. Embrace's approach combines expertise from various fields, including IT and pharmaceuticals, to address significant challenges in the medical care sector.
Dr.JOY
Corporate Round in 2019
Dr.JOY is a digital platform designed to streamline hospital operations worldwide. It offers services such as attendance management, automated location tracking, inter-hospital cooperation, and drug information search, aiming to reduce wasteful workflows and enhance efficiency for healthcare professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.